Literature DB >> 19273599

miR-181a regulates cap-dependent translation of p27(kip1) mRNA in myeloid cells.

Rafael Cuesta1, Aida Martínez-Sánchez, Fátima Gebauer.   

Abstract

p27(kip1) (p27) is a cell cycle inhibitor and tumor suppressor whose expression is tightly regulated in the cell. Translational control of p27 mRNA has emerged as a prominent mechanism to regulate p27 expression during differentiation, quiescence, and cancer progression. The microRNAs miR-221 and miR-222 repress p27 expression in various cancer cells, and this repression promotes tumor cell proliferation. In addition, the presence of an internal ribosome entry site in the 5' untranslated region (UTR) of p27 mRNA has been reported. Here, we show that p27 mRNA is translated via a cap-dependent mechanism in HeLa and HL60 cells and that the previously reported IRES activity can be attributed to cryptic promoters in the sequence corresponding to the p27 5' UTR. Furthermore, cap-dependent translation of p27 mRNA is repressed by miR-181a in undifferentiated HL60 cells. Repression by miR-181a is relieved during differentiation of HL60 into monocyte-like cells, allowing the accumulation of p27, which is necessary to fully block cell cycle progression and reach terminal differentiation. These results identify miR-181a as a regulator of p27 mRNA translation during myeloid cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273599      PMCID: PMC2682024          DOI: 10.1128/MCB.01971-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  The major transcription initiation site of the p27Kip1 gene is conserved in human and mouse and produces a long 5'-UTR.

Authors:  J Coleman; M Hawkinson; R Miskimins; W K Miskimins
Journal:  BMC Mol Biol       Date:  2001-10-11       Impact factor: 2.946

2.  Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation.

Authors:  W K Miskimins; G Wang; M Hawkinson; R Miskimins
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  Translational control of p27Kip1 accumulation during the cell cycle.

Authors:  L Hengst; S I Reed
Journal:  Science       Date:  1996-03-29       Impact factor: 47.728

4.  Induced differentiation of U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression.

Authors:  N Y Rots; A Iavarone; V Bromleigh; L P Freedman
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

5.  Polypyrimidine tract-binding protein enhances the internal ribosomal entry site-dependent translation of p27Kip1 mRNA and modulates transition from G1 to S phase.

Authors:  Sungchan Cho; Jong Heon Kim; Sung Hoon Back; Sung Key Jang
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

6.  Molecular cloning and characterization of the human p27Kip1 gene promoter.

Authors:  S Minami; N Ohtani-Fujita; E Igata; T Tamaki; T Sakai
Journal:  FEBS Lett       Date:  1997-07-07       Impact factor: 4.124

Review 7.  Regulation of the cdk inhibitor p27 and its deregulation in cancer.

Authors:  J Slingerland; M Pagano
Journal:  J Cell Physiol       Date:  2000-04       Impact factor: 6.384

8.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

9.  Regulation of p27Kip1 by miRNA 221/222 in glioblastoma.

Authors:  Jana K Gillies; Ian A J Lorimer
Journal:  Cell Cycle       Date:  2007-05-31       Impact factor: 4.534

10.  MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis.

Authors:  S Debernardi; S Skoulakis; G Molloy; T Chaplin; A Dixon-McIver; B D Young
Journal:  Leukemia       Date:  2007-03-01       Impact factor: 11.528

View more
  36 in total

Review 1.  Alternative ways to think about cellular internal ribosome entry.

Authors:  Wendy V Gilbert
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

2.  MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis.

Authors:  Elzbieta Gocek; Xuening Wang; Xiuping Liu; Chang-Gong Liu; George P Studzinski
Journal:  Cancer Res       Date:  2011-08-04       Impact factor: 12.701

Review 3.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

4.  miR-1247 functions by targeting cartilage transcription factor SOX9.

Authors:  Aida Martinez-Sanchez; Chris L Murphy
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

5.  miR-181a regulates erythroid enucleation via the regulation of Xpo7 expression.

Authors:  Amalia Avila Figueroa; James D Fasano; Sandra Martinez-Morilla; Srividhya Venkatesan; Gary Kupfer; Shilpa M Hattangadi
Journal:  Haematologica       Date:  2018-03-22       Impact factor: 9.941

Review 6.  miRNA response to DNA damage.

Authors:  Guohui Wan; Rohit Mathur; Xiaoxiao Hu; Xinna Zhang; Xiongbin Lu
Journal:  Trends Biochem Sci       Date:  2011-07-07       Impact factor: 13.807

7.  Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts.

Authors:  Hao Hu; Yi Zhang; Xian-Hua Cai; Ji-Feng Huang; Lin Cai
Journal:  Oncol Lett       Date:  2012-08-16       Impact factor: 2.967

8.  Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia.

Authors:  Etienne Moussay; Valérie Palissot; Laurent Vallar; Hélène A Poirel; Thomas Wenner; Victoria El Khoury; Nasséra Aouali; Kris Van Moer; Bernadette Leners; François Bernardin; Arnaud Muller; Pascale Cornillet-Lefebvre; Alain Delmer; Caroline Duhem; Fernand Ries; Eric van Dyck; Guy Berchem
Journal:  Mol Cancer       Date:  2010-05-20       Impact factor: 27.401

9.  14-3-3ζ orchestrates mammary tumor onset and progression via miR-221-mediated cell proliferation.

Authors:  Sumaiyah K Rehman; Shau-Hsuan Li; Shannon L Wyszomierski; Qingfei Wang; Ping Li; Ozgur Sahin; Yi Xiao; Siyuan Zhang; Yan Xiong; Jun Yang; Hai Wang; Hua Guo; Jitao D Zhang; Daniel Medina; William J Muller; Dihua Yu
Journal:  Cancer Res       Date:  2013-11-06       Impact factor: 12.701

10.  MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.

Authors:  R Su; H-S Lin; X-H Zhang; X-L Yin; H-M Ning; B Liu; P-F Zhai; J-N Gong; C Shen; L Song; J Chen; F Wang; H-L Zhao; Y-N Ma; J Yu; J-W Zhang
Journal:  Oncogene       Date:  2014-09-01       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.